BioPorto A/S (THOXF)
OTCMKTS
· Delayed Price · Currency is USD
0.2880
+0.0580 (25.22%)
At close: Jun 26, 2024
BioPorto Revenue
BioPorto had revenue of 7.67M DKK in the quarter ending March 31, 2025, a decrease of -18.96%. This brings the company's revenue in the last twelve months to 34.45M, up 6.40% year-over-year. In the year 2024, BioPorto had annual revenue of 36.24M with 17.07% growth.
Revenue (ttm)
34.45M DKK
Revenue Growth
+6.40%
P/S Ratio
19.17
Revenue / Employee
717.69K DKK
Employees
48
Market Cap
95.70M USD
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 36.24M | 5.29M | 17.07% |
| Dec 31, 2023 | 30.96M | 1.99M | 6.87% |
| Dec 31, 2022 | 28.97M | 4.72M | 19.44% |
| Dec 31, 2021 | 24.25M | 1.05M | 4.53% |
| Dec 31, 2020 | 23.20M | -3.42M | -12.84% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |
BioPorto News
- 5 weeks ago - BioPorto A/S to host first quarter 2025 earnings webcast for investors - GlobeNewsWire
- 6 weeks ago - BioPorto announces completion of an oversubscribed directed offering of 25 million new shares raising DKK 33.5 million - GlobeNewsWire
- 6 weeks ago - BioPorto A/S raises DKK 33.5 million in new capital round - Change of number of shares and votes - GlobeNewsWire
- 7 weeks ago - Correction: Private placement of 25,000,000 new shares fully subscribed – gross proceeds of DKK 33.5 million, to BioPorto A/S - GlobeNewsWire
- 7 weeks ago - Private placement of 25,000,000 new shares fully subscribed – gross proceeds of DKK 33.5 million, to BioPorto A/S - GlobeNewsWire
- 7 weeks ago - BioPorto A/S initiates a private placement of up to 25,000,000 new shares at market price. The Board of Directors has received advance indications for the full offering which is expected to raise proceeds of DKK 33.5 million. - GlobeNewsWire
- 2 months ago - Notice convening the Annual General Meeting in BioPorto A/S - GlobeNewsWire
- 2 months ago - BioPorto announces the Annual Report for 2024 - GlobeNewsWire